Does the FDA drop the ball on drug warning labels?
Drug companies write their own drug labels and submit the results of their clinical studies to the FDA. It’s then up to the FDA to review it and ensure that the most critical information makes it on to the drug label. But sometimes facts about side effects and effectiveness are left out and as a result clinicians aren't always getting the prescribing information they need. Is it a result of incomplete or badly organized information
Drug companies write their own drug labels and submit the results of their clinical studies to the FDA. It’s then up to the FDA to review it and ensure that the most critical information makes it on to the drug label. But sometimes facts about side effects and effectiveness are left out and as a result clinicians aren't always getting the prescribing information they need. Is it a result of incomplete or badly organized information submitted by the drug companies or is the FDA's review process to blame?
Guest:
Dr. Steven Woloshin, associate professor of medicine & of community and family medicine at Dartmouth Medical School; Author of “Lost in Transmission-FDA Drug Information That Never Reaches Clinicians
- Patt Morrison for November 4, 2009
- How Phillip Garrido got away with it…and what it says about California’s parolees
- Why is hunger so young in America?
- Do you have the One Shoe Blues?
- The Obama phenomenon, 1-year later
- Does the FDA drop the ball on drug warning labels?
- Barry Levinson’s Poliwood and its liberal elites
Also on this episode
Events
Comedy Congress Live
Wednesday, February 29, 2012
7:30 p.m.
- 9 p.m.
The comedic material emanating from Washington D.C., and state capitols across the country, is enough to make any sitcom writer jealous, even if most of that comedy is unintentional. Our motto on Comedy Congress is that just when politics makes you want to cry, it’s usually best to laugh.
... » More info
